Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Obalon Therapeutics, Inc. (NASDAQ: OBLN).

Full DD Report for OBLN

You must become a subscriber to view this report.


Recent News from (NASDAQ: OBLN)

Obalon Therapeutics' (OBLN) CEO Andrew Rasdal on Q1 2018 Results - Earnings Call Transcript
Obalon Therapeutics (OBLN) Q1 2018 Earnings Conference Call May 10, 2018 5:00 PM ET Executives William Plovanic - Chief Financial Officer Andrew Rasdal - President and Chief Executive Officer Analysts Rick Wise - Stifel, Nicolaus & Company Ryan Zimmerman - BTIG Brando...
Source: SeekingAlpha
Date: May, 12 2018 14:29
Midday Gainers / Losers (05/11/2018)
Gainers:  ANFI +83% . HEAR +48% . TTD +40% . ARCB +28% . WOW +28% . OMER +24% . MOSY +24% . BOXL +20% . BLNK +20% . EOLS +17% . More news on: Amira Nature Foods, Turtle Beach Corporation, The Trade Desk, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: May, 11 2018 12:41
Obalon down 32% on soft Q1 sales
Thinly traded nano cap Obalon Therapeutics ( OBLN -31.5% ) slumps on more than a 4x surge in volume, albeit on turnover of only 277K shares, in response to its Q1 results that fell shy of consensus. More news on: Obalon Therapeutics, Healthcare stocks news, Earnings news and commentary...
Source: SeekingAlpha
Date: May, 11 2018 11:31
Obalon Therapeutics misses by $0.21, misses on revenue
Obalon Therapeutics (NASDAQ: OBLN ): Q1 EPS of -$0.71 misses by $0.21 . More news on: Obalon Therapeutics, Earnings news and commentary, Healthcare stocks news, , Read more ...
Source: SeekingAlpha
Date: May, 10 2018 16:06
Obalon Announces First Quarter 2018 Financial Results
SAN DIEGO, May 10, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced its unaudited f...
Source: GlobeNewswire
Date: May, 10 2018 16:01
Todd Wood joins Obalon Therapeutics, Inc. as Vice President Global Sales
SAN DIEGO, May 07, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company, announced today that Todd Wood has joined as Vice President Global Sales. Mr. Wood will be responsible for leading field sales, product specialists, sales...
Source: GlobeNewswire
Date: May, 07 2018 16:06
Obalon Schedules First Quarter 2018 Financial Results Conference Call for May 10, 2018 at 5:00 p.m. Eastern Time
SAN DIEGO, May 04, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, today announced that it plans to rel...
Source: GlobeNewswire
Date: May, 04 2018 10:01
DEADLINE TODAY: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Obalon Therapeutics, Inc. and Reminds Investors With Losses in Excess of $50,000 to Contact The Firm
LOS ANGELES, CA / ACCESSWIRE / April 16, 2018 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Obalon Therapeutics, Inc. ("Obalon" or "the Company") (NASDAQ: OBLN ) for violations of §§10(b) and 20(a) of...
Source: ACCESSWIRE IA
Date: April, 16 2018 11:10
DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Securities Class Action Lawsuit Against Obalon Therapeutics, Inc. and Reminds Investors With Losses in Excess of $50,000 to Contact The Firm
LOS ANGELES, CA / ACCESSWIRE / April 13, 2018 / The Schall Law Firm , a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Obalon Therapeutics, Inc. ("Obalon" or "the Company") (NASDAQ: OBLN ) for violations of §§10(b) and 20(a) of...
Source: ACCESSWIRE
Date: April, 13 2018 11:35
April 16th Deadline Alert: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Obalon Therapeutics, Inc. (OBLN)
Law Offices of Howard G. Smith reminds investors of the April 16, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ: OBLN ) securities...
Source: Business Wire
Date: April, 12 2018 21:01

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-182.682.632.762.585118,800
2018-05-172.632.622.662.6062,892
2018-05-162.882.602.882.60166,840
2018-05-152.802.832.832.65168,578
2018-05-142.942.822.942.80199,703

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-05-2151,47863,23881.4036Short
2018-05-1847,48754,17787.6516Short
2018-05-1728,14743,46564.7579Short
2018-05-1646,12671,58364.4371Short
2018-05-1545,967110,79641.4880Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on OBLN.


About Obalon Therapeutics, Inc. (NASDAQ: OBLN)

Logo for Obalon Therapeutics, Inc. (NASDAQ: OBLN)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $50,195,597 - 05/11/2018
  • Issue and Outstanding: 17,612,490 - 02/27/2018

 


Recent Filings from (NASDAQ: OBLN)

Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: May, 11 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 10 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 04 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 30 2018
Additional proxy soliciting materials - definitive
Filing Type: DEFA14AFiling Source: edgar
Filing Date: April, 30 2018
Preliminary proxy statement providing notification matters to be brought to a vote
Filing Type: PRE 14AFiling Source: edgar
Filing Date: April, 19 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 05 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: March, 05 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 22 2018

 

 


Daily Technical Chart for (NASDAQ: OBLN)

Daily Technical Chart for (NASDAQ: OBLN)


Stay tuned for daily updates and more on (NASDAQ: OBLN)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: OBLN)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

The Subway Trader
@TheSubwayTrader

 

 


Disclaimer: The Subway Trader publishes reports providing information on selected companies. The Subway Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. The Subway Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in OBLN is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. The Subway Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. The Subway Trader does not own any shares of OBLN and does not buy, sell, or trade any shares of OBLN. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by The Subway Trader. All rights reserved. Our Full Disclaimer: http://thesubwaytrader.com/disclaimer/